论文信息 - A phase I dose-escalation study of MEDI-575, a PDGFRα monoclonal antibody, in adults with advanced solid tumors - 字舞流文

A phase I dose-escalation study of MEDI-575, a PDGFRα monoclonal antibody, in adults with advanced solid tumors

N. Vogelzang | Shengyan Hong | C. Becerra | R. Narwal | M. Liang | F. Tavakkoli | P. Conkling | N. Pandya | H. Wu